Davy
the recent Ann outlining the Kincell deal to relieve Imugene of the running cost and control of the Azercel manufacturing plant stated that there will be a US$32 cost saving over three years, which I take to be the total , ie US$10.6 per annum. Imugene should have been clearer in the quarterly to explain the reduction once again going forward, so investors can compare quarterly/annual cash burn to cash on hand etc, establishing a rough time frame. There is a further US $ 13m payment due in August for Azercel I believe.
In any event a B cell sale needs to happen pronto to avoid any further potentially disastrous and dilutive CR as per late last year.
- Forums
- ASX - By Stock
- IMU
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-108
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.7¢ | 5.8¢ | 5.6¢ | $1.040M | 18.27M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1917207 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 653942 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1917207 | 0.056 |
14 | 3386705 | 0.055 |
25 | 3644629 | 0.054 |
15 | 2901167 | 0.053 |
19 | 1811203 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 653942 | 7 |
0.059 | 3329802 | 11 |
0.060 | 1565197 | 16 |
0.061 | 2979688 | 13 |
0.062 | 332268 | 4 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |